Cantex Pharmaceuticals

Cantex secures license to develop small molecule-drug for inflammatory lung diseases
Pharmaforum
Thu, 02/24/22 - 09:27 am
Cantex Pharmaceuticals
Harvard
small molecule drugs
azeliragon